HR Execs on the Move

Proof Diagnostics

www.proofdx.com

 
At Proof, we believe that knowledge is power—and good health is a necessity. We`re a health technology and diagnostics company that is currently developing a cutting-edge, CRISPR-based platform for point-of-care facilities to test for COVID-19, with ambitions to transform in-home diagnostics across a broad spectrum of health applications in the future. Proof is the brainchild of Professor Feng Zhang, a world-renowned molecular biologist and leader of a research lab at the Broad Institute of MIT and Harvard. In early 2020, Dr. Zhang along with Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh of the McGovern Institute pivoted their focus towards combating ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Sid Shenai
Co Founder and Chief Executive Officer Profile
Adam Henry
Senior Vice President of Corporate Development Profile

Similar Companies

Synoptics

Synoptics was formed in 1985 by three researchers from the University of Cambridge who had developed a `tool box` for the generation of image analysis applications. The business grew quickly with many major companies using Synoptics to help develop imaging solutions across a wide range of applications. With a growing knowledge of CCD camera technology, frame grabbing and image capture techniques the company was able to enhance its skill sets within digital imaging.

ArthroCare Corporation

ArthroCare Corporation (ArthroCare) is a medical device company that develops, manufactures and markets surgical products, many of which are based on its Coblation technology. The Company markets surgical products across three business units: ArthroCare

xiqi biomedical instrument co.,ltd

xiqi biomedical instrument co.,ltd is a Taizhou, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elucid

Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe

Gemco Medical

Gemco Medical is a Hudson, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.